Intelligo

Private limited company · Vestby

APOTEKET I SON AS

ActiveRetail sale of pharmaceutical products (47.730)

Founded
19 Sep 2007
Employees
22
Chief executive
Inge Valle Tangen
Business address
Kolåsveien 4, 1555 Son

The life line 2007–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 45.9m.

  1. Managing director took office§ 07
  2. Chair took office§ 07
  3. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

APOTEKET I SON AS is a private limited company in Vestby, founded in 2007, in the industry retail sale of pharmaceutical products. The chief executive is Inge Valle Tangen, and the chair of the board is Are Egeland. In 2025 the company had NOK 45.9m in operating revenue and a net profit of NOK 1.5m. The largest owner is EGELAND HOLDING AS with 50.0%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 13 Nov 2026

  • Number of employees 28 → 22
  • Number of employees 26 → 28
  • Annual accounts filed 2024 → 2025
  • Number of employees 25 → 26

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

None registered

None of the rules apply.The rules are fixed: bankruptcy, missing annual accounts, three years of losses, negative equity and the like. Checked 15 Nov 2026.

Overview

§ 03 Key figures

Revenue NOK 45.9m in 2025

Revenue

NOK 45.9m

+5.4% from 2024

20232025

Operating profit

NOK 1.9m

+27.1% from 2024

20232025

Net profit

NOK 1.5m

+26.5% from 2024

20232025

Equity

NOK 120k

+9.5% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 16%
  • Depreciation 0%
  • Other operating costs 4%
  • Not specified in the source 76%
  • Left as operating result 4%

Of the net profit for 2025, NOK 10k stayed in the company. The rest, NOK 1.5m, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 1.5%

RevenueNOK 45.9m Operating margin4.2% Equity ratio1.5% Revenue growth+5.4%
  • APOTEKET I SON AS, 2025
  • Industry median, assumed: NOK 19.4m · 2.5% · 14.5% · +6.6%

Equity NOK 120k1% of the assets (NOK 8.3m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 223 companies in 47.730 Retail sale of pharmaceutical products, not stated by the source.

Finances

§ 06 Accounts

19 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue45,93443,58039,140
Operating profit1,9161,5071,376
Profit before tax1,9161,5111,375
Net profit1,4901,1781,072
Total assets8,2717,75111,007
Equity120110931
Liabilities8,1517,64110,076

Source: the Register of Company Accounts, read 15 Nov 2026 · All 19 years →

Management and ownership

§ 07 Officers

5 officers now

The board: 2 members

Source: the Brønnøysund Register Centre, read 16 Sep 2026 · All 5 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Daglig leder og styrets leder i fellesskap.

May sign for the company:

Daglig leder og styrets leder i fellesskap.

Power of procuration:

Daglig leder alene.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 24 Aug 2026

Management and ownership

§ 09 Owners

2 shareholders · largest 50.0%

OwnerShare
EGELAND HOLDING AS
50.0%
VALLE TANGEN AS
50.0%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 2 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

7 connections

  • Person
  • Company

2 people link APOTEKET I SON AS to 3 other companies: Are Egeland 2 and Inge Valle Tangen 2.

Source: the Brønnøysund Register Centre, read 16 Sep 2026 · Explore the network →

Events and registers

§ 13 Events

21 since 2015

Events per year

20152026

  • Notices25
  • Register changes5

Since 2015: 25 announcements and 5 register changes. Most happened in 2022 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 21 events →

Events and registers

§ 14 Notices

25, latest 20 Jun 2026

  • Godkjente årsregnskap
  • Godkjente årsregnskap
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 25 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 19 Sep 2007
  • VATRegistered
  • The Register of Business EnterprisesRegistered 19 Sep 2007
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Salg av legemidler og helserelaterte produkter samt naturlig tilhørende handelsvarer, fortrinnsvis ved apotekdrift, samt hva hermed står i forbindelse herunder å delta i andre selskaper.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 47.730

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of APOTEKET I SON AS?
    Inge Valle Tangen, since 2022. § 07
  • Who owns APOTEKET I SON AS?
    2 shareholders. The largest is EGELAND HOLDING AS with 50.0% and VALLE TANGEN AS with 50.0%. § 09
  • What was the revenue in 2025?
    NOK 45.9m in the company. § 06
  • Who can sign for APOTEKET I SON AS?
    Daglig leder og styrets leder i fellesskap. § 08
  • Who is the auditor?
    REVISORKONSULT AS, from 19 Sep 2007. § 07
  • Where is APOTEKET I SON AS based?
    Kolåsveien 4, 1555 Son.
  • When was APOTEKET I SON AS founded?
    19 Sep 2007, registered in the Register of Business Enterprises 19 Sep 2007. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose